Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment

by Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trabka, Christoph Sowada, Andrzej Pilc, Andrzej Pilc
Published 2018-11-01

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

by Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trąbka, Christoph Sowada, Guenka Petrova, Manoela Manova, Alexandra Savova, Pero Draganić, Juraj Slabý, Agnes Männik, Kristóf Márky, Zinta Rugaja, Jolanta Gulbinovic, Tomas Tesar, Marian Sorin Paveliu
Published 2020-10-01

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries

by Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trąbka, Marcin Czech, Guenka Petrova, Manoela Manova, Manoela Manova, Alexandra Savova, Alexandra Savova, Pero Draganić, Pero Draganić, Lenka Vostalová, Juraj Slabý, Agnes Männik, Kristóf Márky, Zinta Rugaja, Jolanta Gulbinovic, Tomas Tesar, Marian Sorin Paveliu
Published 2019-05-01